Molecular interactions of cyclosporin A with P-glycoprotein - Photolabeling with cyclosporin derivatives

被引:38
|
作者
Demeule, M
Wenger, RM
Beliveau, R
机构
[1] UNIV QUEBEC,HOP ST JUSTINE,MOL ONCOL LAB,DEPT CHIM BIOCHIM,MONTREAL,PQ H3C 3P8,CANADA
[2] SANDOZ PHARMA LTD,CH-4002 BASEL,SWITZERLAND
关键词
D O I
10.1074/jbc.272.10.6647
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interaction between P-glycoprotein (140-180 kDa) from the multidrug-resistant Chinese hamster ovary cell line CH(R)C5 and cyclosporin A was characterized using three different photoactivable cyclosporin A analogs. Two monoclonal antibodies, which are able to discriminate between two major domains of cyclosporin A (the cyclophilin and calcineurin binding domains), were used to detect the photolabeled proteins. A protein of 155 kDa corresponding to P-glycoprotein was much more strongly photolabeled in membranes of CH(R)C5 cells than in membranes of their drug-sensitive parent cell line AuxB1. The antitumor drug vinblastine and the reversal agents verapamil and cyclosporin A inhibited the photolabeling, and the nonimmunosuppressive derivative PSC-833 caused a stronger inhibition than cyclosporin A. P-glycoprotein photolabeled with cyclosporin A analogs was only detected with the monoclonal antibody that recognizes cyclosporin A and its metabolites, indicating that the calcineurin binding domain recognized specifically by the other antibody is not exposed. These results suggest that the portion of cyclosporin A that binds to calcineurin plays a role in the interaction of cyclosporin A with P-glycoprotein.
引用
收藏
页码:6647 / 6652
页数:6
相关论文
共 50 条
  • [1] Interactions of cyclosporin with P-glycoprotein:: Photolabeling with cyclosporin-derivatives.
    Demeule, M
    Wenger, RM
    Béliveau, R
    FASEB JOURNAL, 1997, 11 (09): : A1253 - A1253
  • [2] Interaction of cyclosporin derivatives with the ATPase activity of human P-glycoprotein
    Watanabe, T
    Kokubu, N
    Charnick, SB
    Naito, M
    Tsuruo, T
    Cohen, D
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 (02) : 241 - 248
  • [3] Inhibition of P-glycoprotein by cyclosporin A analogues and metabolites
    Demeule, M
    Laplante, A
    Sepehr-Araé, A
    Beaulieu, É
    Averill-Bates, D
    Wenger, RM
    Béliveau, R
    BIOCHEMISTRY AND CELL BIOLOGY, 1999, 77 (01) : 47 - 58
  • [4] Identification of the cyclosporin-binding site in P-glycoprotein
    Demeule, M
    Laplante, A
    Murphy, GF
    Wenger, RM
    Béliveau, R
    BIOCHEMISTRY, 1998, 37 (51) : 18110 - 18118
  • [5] Limited role of P-glycoprotein in the intestinal absorption of cyclosporin A
    Lee, YJ
    Chung, SJ
    Shim, CK
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (04) : 760 - 763
  • [6] In vitro P-glycoprotein up-regulation by cyclosporin.
    Lian, AJ
    Gao, W
    Ito, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P27 - P27
  • [7] Human P-glycoprotein transports cyclosporin A and FK506
    1600, American Society for Biochemistry and Molecular Biology Inc., Bethesda, United States (268):
  • [8] Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: In vitro in vivo correlation
    Fricker, G
    Drewe, J
    Huwyler, J
    Gutmann, H
    Beglinger, C
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (07) : 1841 - 1847
  • [9] Relevance of P-glycoprotein for the transport of cyclosporin A across intestine, liver and kidney
    Fricker, G
    Drewe, J
    Miller, D
    HEPATOLOGY, 1997, 26 (04) : 13 - 13
  • [10] Potentiation of domperidone-induced catalepsy by a P-glycoprotein inhibitor, cyclosporin A
    Tsujikawa, K
    Dan, Y
    Nogawa, K
    Sato, H
    Yamada, Y
    Murakami, H
    Ohtani, H
    Sawada, Y
    Iga, T
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2003, 24 (03) : 105 - 114